Conflicting results have been published considering the role of head-up tilt test (HUTT) positivity as a prognostic factor in patients with hypertrophic cardiomyopathy (HCM). The relationship between HCM patients' genotype and their HUTT results has not been previously reported. The aim of this study was to evaluate patients with HCM and their HUTT results in regard to its value for outcome prediction and to investigate the relation of patients' genotype and their HUTT results. Seventy-four (51 ± 15 years; 42% women; median follow-up 72 months) HCM patients were divided into two groups based on their HUTT results and were retrospectively analyzed. In 67 (90.5%) subjects included in the analysis, next-generation sequencing-based genomic testing was performed. A composite end point of unexplained syncope, heart failure hospitalization, and death was defined. A total of 14 patients (18.9%) had positive HUTT (HUTT+), whereas 60 (81.1%) had negative HUTT (HUTT-). Except for the New York Heart Association functional class ( p = 0.01), both groups had similar characteristics. Positive genotype was evenly distributed between the two groups. Composite end point occurred in 5 patients (35.7%) in HUTT+ group versus 14 (23.3%) patients in HUTT- group ( p = 0.33). We did not find a relationship between HUTT results and long-term outcome. We found no association between HUTT results and genotype.

Department of Cardiology 2nd Faculty of Medicine and Motol University Hospital Prague Czech Republic

Zobrazit více v PubMed

Buja G, Melacini P, Folino A, Miorelli M, Nava A. Spontaneous and induced vasodepressor/vasovagal syncope in hypertrophic cardiomyopathy. Clin Cardiol. 1992;15(05):387–389. PubMed

Sutton R, Brignole M. Twenty-eight years of research permit reinterpretation of tilt-testing: hypotensive susceptibility rather than diagnosis. Eur Heart J. 2014;35(33):2211–2212. PubMed

Sneddon J F, Slade A, Seo H, Camm A J, McKenna W J. Assessment of the diagnostic value of head-up tilt testing in the evaluation of syncope in hypertrophic cardiomyopathy. Am J Cardiol. 1994;73(08):601–604. PubMed

Manganelli F, Betocchi S, Ciampi Q et al. Comparison of hemodynamic adaptation to orthostatic stress in patients with hypertrophic cardiomyopathy with or without syncope and in vasovagal syncope. Am J Cardiol. 2002;89(12):1405–1410. PubMed

Forleo C, Guida P, Iacoviello M et al. Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. Int J Cardiol. 2013;168(01):27–35. PubMed

Elliott P M, Poloniecki J, Dickie S et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36(07):2212–2218. PubMed

Spirito P, Autore C, Rapezzi C et al. Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. 2009;119(13):1703–1710. PubMed

Elliott P M, Anastasakis A, Borger M A et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J. 2014;35(39):2733–2779. PubMed

Gersh B J, Maron B J, Bonow R O et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2011;124(24):e783–e831. PubMed

Veselka J, Anavekar N S, Charron P.Hypertrophic obstructive cardiomyopathy Lancet 2017389(10075):1253–1267. PubMed

Cooper R M, Raphael C E, Liebregts M, Anavekar N S, Veselka J. New developments in hypertrophic cardiomyopathy. Can J Cardiol. 2017;33(10):1254–1265. PubMed

Richards S, Aziz N, Bale S et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(05):405–424. PubMed PMC

Bonaventura J, Norambuena P, Tomasov P et al. The utility of the Mayo Score for predicting the yield of genetic testing in patients with hypertrophic cardiomyopathy. Arch Med Sci. 2019;15(03):641–649. PubMed PMC

Dimitrow P P, Chojnowska L, Rudzinski T et al. Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up. Eur Heart J. 2010;31(24):3084–3093. PubMed

Gilligan D M, Nihoyannopoulos P, Chan W L, Oakley C M. Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy. Use of a head-up tilt test. Circulation. 1992;85(06):2140–2148. PubMed

Thomson H L, Morris-Thurgood J, Atherton J, Frenneaux M. Reduced cardiopulmonary baroreflex sensitivity in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1998;31(06):1377–1382. PubMed

Williams L, Frenneaux M. Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment. Europace. 2007;9(09):817–822. PubMed

Brignole M, Moya A, de Lange F J et al. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883–1948. PubMed

Thaman R, Elliott P M, Shah J S et al. Reversal of inappropriate peripheral vascular responses in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46(05):883–892. PubMed

Sadoul N, Prasad K, Elliott P M, Bannerjee S, Frenneaux M P, McKenna W J. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation. 1997;96(09):2987–2991. PubMed

Thomson H L, Morris-Thurgood J, Atherton J, McKenna W J, Frenneaux M P. Reflex responses of venous capacitance vessels in patients with hypertrophic cardiomyopathy. Clin Sci (Lond) 1998;94(04):339–346. PubMed

Ungar A, Sgobino P, Russo V et al. Diagnosis of neurally mediated syncope at initial evaluation and with tilt table testing compared with that revealed by prolonged ECG monitoring. An analysis from the Third International Study on Syncope of Uncertain Etiology (ISSUE-3) Heart. 2013;99(24):1825–1831. PubMed

Macatrão-Costa M F, Arteaga-Fernandez E, de Brito F S et al. Evaluation of the autonomic function in patients with hypertrophic cardiomyopathy with and without syncope. Arq Bras Cardiol. 2013;100(02):180–186. PubMed